Injective (INJ) has finally broken free from months of downward pressure, igniting a wave of bullish momentum across the market. After an extended consolidation phase that began in late 2024, INJ is now pushing higher with conviction, clearing a descending channel and shifting sentiment in its favor. At the time of writing, INJ is trading…
This article is provided solely for informational and educational purposes and does not constitute financial or investment advice, a recommendation, or an offer or solicitation to buy or sell any financial instrument or digital asset. See our Financial Disclaimer.
This article was generated with the support of AI and reviewed by the Editorial Team. For more information, see our Terms of Service.









